| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
9,590 |
7,914 |
$545K |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
13,622 |
12,273 |
$434K |
| 80053 |
Comprehensive metabolic panel |
11,026 |
9,306 |
$356K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
12,929 |
10,841 |
$342K |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
3,195 |
2,498 |
$309K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,584 |
4,956 |
$193K |
| 36415 |
Collection of venous blood by venipuncture |
19,589 |
15,717 |
$182K |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
687 |
656 |
$170K |
| 70450 |
Computed tomography, head or brain; without contrast material |
706 |
635 |
$170K |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
599 |
573 |
$87K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
1,106 |
1,065 |
$72K |
| 71046 |
Radiologic examination, chest; 2 views |
1,555 |
1,390 |
$69K |
| 87070 |
|
1,521 |
1,415 |
$64K |
| 84443 |
Thyroid stimulating hormone (TSH) |
3,168 |
2,854 |
$62K |
| 81001 |
|
3,534 |
3,142 |
$54K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
2,532 |
2,226 |
$49K |
| G0378 |
Hospital observation service, per hour |
434 |
202 |
$45K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
1,507 |
1,258 |
$44K |
| 86140 |
|
2,928 |
2,556 |
$39K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
1,427 |
1,250 |
$36K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
616 |
519 |
$35K |
| 82150 |
|
2,297 |
2,000 |
$34K |
| 83690 |
|
2,307 |
2,003 |
$34K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
300 |
226 |
$33K |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
274 |
220 |
$31K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
1,043 |
993 |
$31K |
| 80061 |
Lipid panel |
894 |
831 |
$27K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
583 |
511 |
$24K |
| 84484 |
|
1,144 |
963 |
$22K |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
965 |
927 |
$19K |
| 82607 |
|
692 |
665 |
$19K |
| 83735 |
|
1,115 |
962 |
$16K |
| 83880 |
|
722 |
614 |
$12K |
| 87040 |
|
410 |
347 |
$12K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
499 |
406 |
$12K |
| 80306 |
|
271 |
241 |
$11K |
| 62323 |
|
43 |
39 |
$11K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
15 |
14 |
$9K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
31 |
29 |
$9K |
| 83605 |
|
659 |
563 |
$9K |
| 85610 |
|
889 |
775 |
$9K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
702 |
659 |
$9K |
| 84145 |
|
482 |
396 |
$8K |
| 82728 |
|
204 |
192 |
$8K |
| 80320 |
|
259 |
224 |
$8K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
311 |
278 |
$7K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
328 |
289 |
$7K |
| 87631 |
|
79 |
75 |
$6K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
14 |
14 |
$5K |
| 85652 |
|
805 |
707 |
$5K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
730 |
612 |
$5K |
| 82746 |
|
117 |
110 |
$5K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
126 |
116 |
$5K |
| 84703 |
|
172 |
160 |
$5K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
47 |
12 |
$5K |
| 80329 |
|
60 |
56 |
$4K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
67 |
65 |
$4K |
| 83550 |
|
193 |
178 |
$4K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
32 |
14 |
$4K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
165 |
155 |
$4K |
| 83540 |
|
193 |
178 |
$3K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
132 |
125 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
42 |
38 |
$2K |
| 82803 |
|
76 |
62 |
$2K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
308 |
283 |
$2K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
269 |
237 |
$1K |
| J2704 |
Injection, propofol, 10 mg |
43 |
38 |
$1K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
41 |
38 |
$1K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
86 |
78 |
$1K |
| 84550 |
|
43 |
42 |
$1K |
| J2795 |
Injection, ropivacaine hydrochloride, 1 mg |
183 |
169 |
$1K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
185 |
163 |
$1K |
| 87081 |
|
60 |
58 |
$916.24 |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
140 |
118 |
$897.64 |
| 87480 |
|
38 |
37 |
$719.98 |
| J1040 |
Injection, methylprednisolone acetate, 80 mg |
43 |
39 |
$685.93 |
| 87660 |
|
38 |
37 |
$512.06 |
| 87510 |
|
38 |
37 |
$512.06 |
| 84439 |
|
27 |
26 |
$497.89 |
| 85018 |
|
34 |
31 |
$468.80 |
| 87430 |
|
33 |
32 |
$388.33 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
16 |
15 |
$340.58 |
| 80143 |
|
16 |
14 |
$295.85 |
| 80179 |
|
14 |
12 |
$268.67 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
13 |
13 |
$259.68 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
13 |
13 |
$259.68 |
| J7613 |
Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg |
40 |
37 |
$159.54 |
| 84480 |
|
13 |
12 |
$107.64 |
| 87641 |
|
17 |
12 |
$64.41 |
| 87640 |
|
17 |
12 |
$64.41 |
| J1170 |
Injection, hydromorphone, up to 4 mg |
15 |
12 |
$59.03 |
| J7620 |
Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme |
13 |
13 |
$46.57 |
| 99217 |
|
18 |
13 |
$37.09 |
| P9604 |
Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge |
15 |
13 |
$0.00 |
| A9270 |
Non-covered item or service |
302 |
203 |
$0.00 |